Abstract:
Objective To evaluate the diagnostic efficiency of 99Tcm-sodium toluene sulfonate nicotinamide hydrazone PEGylated bicyclic arginine-glycine-aspatic acid peptide (abbreviation 99Tcm-3PRGD2) SPECT/CT imaging to progressive radioiodine refractory differentiated thyroid cancer (RAIR-DTC) without iodine uptake.
Methods A total of 59 patients with RAIR-DTC who underwent 99Tcm-3PRGD2 SPECT/CT examination in Fujian Provincial Hospital from October 2019 to May 2022 were prospectively selected, including 17 males and 42 females, with a median age of 51 (28, 80) years. All patients underwent 99Tcm-3PRGD2 SPECT/CT, among them, 22 patients were treated with a tyrosine kinase inhibitor (TKI), and 37 patients had thyroid-stimulating hormone (TSH) inhibition 13 patients underwent 18F-fluorodeoxyglucose (FDG) PET/CT within two weeks. Maximum standardized uptake value (SUVmax) of the lesion with the largest-length diameter in each patient was analyzed. The diagnostic efficiency of 99Tcm-3PRGD2 SPECT/CT imaging was evaluated by receiver operating characteristic (ROC) curves analysis and was also used to calculate the SUVmax cut-off value of 99Tcm-3PRGD2 SPECT/CT to assist in the detection of RAIR-DTC lesions. Using Pearson correlation analysis method to analyze the correlations between the target lesion (TL), stimulated thyroglobulin (sTg) levels and SUVmax. The relationships between the sTg levels, SUVmax and TL in RAIR-DTC patients before and after TKI treatment were analyzed by paired t test.
Results A total of 276 lesions from 59 RAIR-DTC patients were included in the analysis. These 59 lesions were compared before and after TKI treatment. The sensitivity and specificity of 99Tcm-3PRGD2 SPECT/CT imaging for the diagnosis of RAIR-DTC lesions were 94.9% (95%CI: 90.7%–97.3%) and 88.7% (95%CI: 77.5%–95.0%), respectively. The ROC curves results showed that the cut-off value of SUVmax for RAIR-DTC lesions detected by 99Tcm-3PRGD2 SPECT/CT imaging was 2.70. The results of the Pearson correlation analysis showed that the SUVmax of the target lesions was positively correlated with the sTg levels and TL (r=0.811, 0.635, both P=0.001). The paired t test results showed that SUVmax in RAIR-DTC lesions was significantly decreased before and after TKI treatment (t=11.027, P=0.001). Spearman correlation analysis showed that there was a positive correlation between 99Tcm-3PRGD2 SPECT/CT imaging and 18F-FDG PET/CT imaging in detecting SUVmax of positive lesions (r=0.560, P=0.001). However, the results of ROC curves analysis did not show statistical significance in the diagnostic efficiency of 99Tcm-3PRGD2 SPECT/CT imaging for RAIR-DTC lesions versus 18F-FDG PET/CT imaging (Z=0.312, P=0.753).
Conclusion 99Tcm-3PRGD2 SPECT/CT imaging had high sensitivity and specificity in the diagnosis of progressive RAIR-DTC without iodine uptake, similar to 18F-FDG PET/CT.